🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital
Start Date
2026-06-30
Trial ID
NCT07717177
Treatments Being Tested
This is an open label, multi-centre, phase Ib/II, parallel arm study evalua...
Status
Unknown
Location
Concord Repatriation General Hospital
Start Date
2021-06-29
Trial ID
NCT04914741
Treatments Being Tested
This is an open-label, single arm, multicenter, dose finding, Phase Ib stud...
Status
Active Not Recruiting
Location
UZ Gent
Start Date
2018-05-08
Trial ID
NCT03533283
Treatments Being Tested
The aim of this study was to analyze the safety and efficacy of CD3-CD20 bi...
Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Start Date
2024-04-30
Trial ID
NCT06464185
Treatments Being Tested
The goal of this phase 2 trial is to test the safety and efficacy of G-Pola...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-24
Trial ID
NCT06665217
This phase II trial tests the safety and side effects of glofitamab and obi...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2026-07-08
Trial ID
NCT07003295
Treatments Being Tested
This Phase II trial evaluates the optimization of the cytokine release synd...
Status
Recruiting
Location
Alaska Oncology & Hematology, LLC
Start Date
2025-03-05
Trial ID
NCT06806033
Treatments Being Tested
The purpose of this study is to find the highest dose of a new drug, in com...
Status
Active Not Recruiting
Location
BCCA - Vancouver
Start Date
2020-09-02
Trial ID
NCT04161248
This phase I trial tests the safety, side effects and best dose of glofitam...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07444710
Assess the efficacy and safety of glofitamab in combination with selinexor ...
Status
Not Yet Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2026-06-10
Trial ID
NCT07669194
Treatments Being Tested